Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $2,958 | 10 | 76.9% |
| Food and Beverage | $888.02 | 20 | 23.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bristol-Myers Squibb Company | $3,442 | 22 | $0 (2017) |
| GE HEALTHCARE | $340.88 | 4 | $0 (2024) |
| Celgene Corporation | $34.07 | 2 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $17.37 | 1 | $0 (2018) |
| Amarin Pharma Inc. | $11.75 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $48.74 | 1 | GE HEALTHCARE ($48.74) |
| 2023 | $292.14 | 3 | GE HealthCare ($292.14) |
| 2019 | $11.75 | 1 | Amarin Pharma Inc. ($11.75) |
| 2018 | $37.34 | 2 | Celgene Corporation ($19.97) |
| 2017 | $3,456 | 23 | Bristol-Myers Squibb Company ($3,442) |
All Payment Transactions
30 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/07/2024 | GE HEALTHCARE | — | Food and Beverage | In-kind items and services | $48.74 | General |
| 03/27/2023 | GE HealthCare | — | Food and Beverage | Cash or cash equivalent | $97.38 | General |
| 03/27/2023 | GE HEALTHCARE | — | Food and Beverage | Cash or cash equivalent | $97.38 | General |
| 03/27/2023 | GE HEALTHCARE | — | Food and Beverage | Cash or cash equivalent | $97.38 | General |
| 11/12/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $11.75 | General |
| Category: Hypertriglyceridemia | ||||||
| 05/14/2018 | Celgene Corporation | Otezla (Drug) | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: Dermatology | ||||||
| 04/11/2018 | Merck Sharp & Dohme Corporation | RENFLEXIS (Biological) | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: IMMUNOLOGY | ||||||
| 07/17/2017 | Celgene Corporation | Otezla (Drug) | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: Dermatology | ||||||
| 03/06/2017 | Bristol-Myers Squibb Company | — | Travel and Lodging | Cash or cash equivalent | $8.00 | General |
| 02/14/2017 | Bristol-Myers Squibb Company | — | Travel and Lodging | Cash or cash equivalent | $825.20 | General |
| 02/14/2017 | Bristol-Myers Squibb Company | — | Travel and Lodging | Cash or cash equivalent | $196.00 | General |
| 02/14/2017 | Bristol-Myers Squibb Company | — | Food and Beverage | Cash or cash equivalent | $53.99 | General |
| 02/14/2017 | Bristol-Myers Squibb Company | — | Food and Beverage | Cash or cash equivalent | $16.48 | General |
| 02/13/2017 | Bristol-Myers Squibb Company | — | Travel and Lodging | Cash or cash equivalent | $479.71 | General |
| 02/13/2017 | Bristol-Myers Squibb Company | — | Food and Beverage | Cash or cash equivalent | $12.13 | General |
| 02/02/2017 | Bristol-Myers Squibb Company | — | Food and Beverage | Cash or cash equivalent | $42.81 | General |
| 01/31/2017 | Bristol-Myers Squibb Company | — | Food and Beverage | Cash or cash equivalent | $34.63 | General |
| 01/30/2017 | Bristol-Myers Squibb Company | — | Travel and Lodging | Cash or cash equivalent | $161.76 | General |
| 01/30/2017 | Bristol-Myers Squibb Company | — | Travel and Lodging | Cash or cash equivalent | $151.17 | General |
| 01/30/2017 | Bristol-Myers Squibb Company | — | Travel and Lodging | Cash or cash equivalent | $141.20 | General |
| 01/30/2017 | Bristol-Myers Squibb Company | — | Travel and Lodging | Cash or cash equivalent | $87.21 | General |
| 01/26/2017 | Bristol-Myers Squibb Company | — | Food and Beverage | Cash or cash equivalent | $46.13 | General |
| 01/25/2017 | Bristol-Myers Squibb Company | — | Travel and Lodging | Cash or cash equivalent | $385.12 | General |
| 01/25/2017 | Bristol-Myers Squibb Company | — | Food and Beverage | Cash or cash equivalent | $49.45 | General |
| 01/25/2017 | Bristol-Myers Squibb Company | — | Food and Beverage | Cash or cash equivalent | $21.08 | General |
About Dr. Thomas Lynch, MD
Dr. Thomas Lynch, MD is a Medical Oncology healthcare provider based in Seattle, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/18/2005. The National Provider Identifier (NPI) number assigned to this provider is 1780666131.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Lynch, MD has received a total of $3,846 in payments from pharmaceutical and medical device companies, with $48.74 received in 2024. These payments were reported across 30 transactions from 5 companies. The most common payment nature is "Travel and Lodging" ($2,958).
Practice Information
- Specialty Medical Oncology
- Location Seattle, WA
- Active Since 11/18/2005
- Last Updated 02/24/2021
- Taxonomy Code 207RX0202X
- Entity Type Individual
- NPI Number 1780666131
Products in Payments
- Otezla (Drug) $34.07
- RENFLEXIS (Biological) $17.37
- Vascepa (Drug) $11.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Oncology Doctors in Seattle
Bart Scott
Medical Oncology — Payments: $1.5M
Petros Grivas, M.d, M.D
Medical Oncology — Payments: $683,103
Evan Yu
Medical Oncology — Payments: $356,321
Gary Lyman, Md, MD
Medical Oncology — Payments: $176,021
Jerald Radich, Md, MD
Medical Oncology — Payments: $171,817
David Maloney
Medical Oncology — Payments: $167,323